Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA7 | P43166 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.47 |
| ▸ | ESR1 | P03372 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14979300 | 0.95 | LMNA (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL300884 | 0.92 | CA12 (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31225538 | 0.92 | PARP10 (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL22046417 | 0.91 | F3 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13455758 | 0.87 | SMN1; SMN2 (0.44) | CA12CA1CA2CA9CA14 | |
| SCHEMBL22046616 | 0.87 | HDAC6 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27717830 | 0.85 | CA1 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9551376 | 0.84 | KMT2A (0.44) | ESR1KMT2AESR2MEN1RAB9A | |
| SCHEMBL317627 | 0.84 | PTPN2 (0.44) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL159204 | 0.84 | KDM4E (0.42) | CA1CA2KMT2AMEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114423781-B | Electrical conductors and methods for conducting ions with troponin | 北京大学 | 2024-03-26 | — | — | CN | disclosed |
| US-8945927-B2 | Polymers for delivering molecules of interest | UNIVERSITE DE STRASBOURG (FR) | 2015-02-03 | — | — | US | disclosed |
| US-8945927-B2 | Polymers for delivering molecules of interest | UNIVERSITE DE STRASBOURG (FR) | 2015-02-03 | — | — | US | disclosed |
| EP-1807436-B1 | HETEROBIFUNCTIONAL POLY(ETHYLENE GLYCOL) AND USES THEREOF | INTEZYNE TECHNOLOGIES INC (US) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013106097-A1 | POLY(ETHYLENE GLYCOL) DERIVATIVES FOR CLICK CHEMISTRY | INTEZYNE TECHNOLOGIES, INC. (US) | 2013-07-18 | — | — | WO | disclosed |
| US-20130178600-A1 | POLY(ETHYLENE GLYCOL) DERIVATIVES FOR CLICK CHEMISTRY | INTEZYNE TECHNOLOGIES, INC. (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130178600-A1 | POLY(ETHYLENE GLYCOL) DERIVATIVES FOR CLICK CHEMISTRY | INTEZYNE TECHNOLOGIES, INC. (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130096177-A1 | POLYMERS FOR DELIVERING MOLECULES OF INTEREST | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-04-18 | — | — | US | disclosed |
| US-20130096177-A1 | POLYMERS FOR DELIVERING MOLECULES OF INTEREST | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-04-18 | — | — | US | disclosed |
| EP-2502941-A1 | Heterobifunctional poly (ethylene glycol) and uses thereof | Intezyne Technologies Inc. (US) | 2012-09-26 | — | — | EP | disclosed |
| US-20030166644-A1 | Compounds and uses thereof for decreasing activity of hormone-sensitive lipase | NOVO NORDISK A/S (DK) | 2003-09-04 | — | — | US | disclosed |
| WO-2003051841-A2 | COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051842-A2 | COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE | NOVO NORDISK A/S (DK) | 2003-06-26 | — | — | WO | disclosed |
| EP-0244836-B1 | TRIPEPTIDE DERIVATIVES | Dainippon Pharmaceutical Co., Ltd. (JP) | 1993-08-18 | — | — | EP | disclosed |
| US-4826814-A | INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1989-05-02 | — | — | US | disclosed |
| EP-0170415-B1 | PHENANTHRIDINIUM ESTER AS A LABELLING COMPOUND IN LUMINOMETRIC IMMUNOASSAY | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1988-04-20 | — | — | EP | disclosed |
| EP-0244836-A2 | Tripeptide derivatives | Dainippon Pharmaceutical Co., Ltd. (JP) | 1987-11-11 | — | — | EP | disclosed |
| US-4687747-A | Phenanthridinium ester as a labelling compound in luminometric immunoassay | MALLINCKRODT, INC. (US) | 1987-08-18 | — | — | US | disclosed |
| EP-0170415-A1 | Phenanthridinium ester as a labelling compound in luminometric immunoassay | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1986-02-05 | — | — | EP | disclosed |
| US-4112219-A | Acyl derivatives of antibiotic BM123γ | AMERICAN CYANAMID COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130096177-A1 | POLYMERS FOR DELIVERING MOLECULES OF INTEREST | PHAX, CD44, SNRPE | CA12 1261/4885CA1 2174/4885CA2 1895/4885 |
| US-20030166644-A1 | Compounds and uses thereof for decreasing activity of hormone-sensitive lipase | LIPE, PNLIP, LPL | CA12 3885/4885CA1 3261/4885CA2 3744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.